Back to search

Article

Impact of lokivetmab for Canine Atopic Dermatitis on Owner and Canine Health-Related Quality of Life and Owner Treatment Satisfaction

2026-03-27

Abstract excerpt

<title>Abstract</title> <p>Background Lokivetmab is a caninised monoclonal antibody that neutralises circulating interleukin‑31 (IL‑31), a cytokine implicated in the pathogenesis of canine atopic dermatitis (AD). The objectives are to evaluate changes in quality of life (QOL) for atopic dogs and their owners, owner treatment satisfaction (TS), and pruritus (PVAS) over 91 days following initiation of lokivetmab i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
668499d4-bc10-58a8-9f7f-eb37582c1937
DOI
10.21203/rs.3.rs-9087690/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of lokivetmab for Canine Atopic Dermatitis on Owner and Canine Health-Related Quality of Life and Owner Treatment SatisfactionDOI 10.21203/rs.3.rs-9087690/v1
Efficacy of p62-expressing plasmid in treatment of canine ATOPIC DERMATITIS: A Pilot study IN companion dogsSemantic proximity
Remote Monitoring of Canine Patients Treated for Pruritus during the COVID Pandemic in Florida Using a 3-D AccelerometerSemantic proximity
A European Field Assessment of the efficacy of fluralaner (Bravecto®) chewable and spot-on formulations for treatment of dogs with generalized demodicosisSemantic proximity
Therapeutic vaccination reverses severe canine leishmaniasis: a case reportSemantic proximity
rhIFN-α14 changes skin microbiota in naturally occurring canine atopic dermatitisSemantic proximity
Evaluation of Symptom and Side Effect Bother in Cutaneous T-cell Lymphoma Patients Treated with Mogamulizumab or VorinostatSemantic proximity
Clinical and histological characterization of multifocal, spontaneous, noninfectious alopecia in Norwegian puffin dogs (lundehunds).Semantic proximity
Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.Semantic proximity
Development of a Core Outcome Measure Instrument; “LeishCOM_LCL”, for Localised Cutaneous LeishmaniasisSemantic proximity
Development and Validation of a Canine Health Related QoL Questionnaire and a Human-Canine Bond Questionnaire for Use in Veterinary PracticeSemantic proximity
A Comprehensive Clinical Evaluation of Levocetirizine in the Treatment of Chronic Urticaria in ChildrenSemantic proximity
Ilunocitinib-Induced Pancytopenia in an Australian Shepherd Dog with the MDR1 Mutation.Semantic proximity
Select a neighboring publication to make it the new centre.